The Future of Medtech

The new edition of EvaluateMedTech™ World Preview 2013, Outlook to 2018 brings together many of our analyses to provide a top level insight into the expected performance of the medtech industry between now and 2018. 

Based on EvaluateMedTech™'s coverage of the world's leading medical device and diagnostic companies, the World Preview highlights trends in medtech including sales and consensus forecasts of leading industry analysts by device area to 2018, the top 20 Companies in 2018, R&D spend current and future, FDA approvals, M&A and Venture Financing and Enterprise Value & Focus Analysis - view the report infographic (PDF). 

Analysis Highlights this year include:

• Worldwide medtech sales forecast to grow by 4.5% (CAGR 2012 to 2018), reaching $455bn by 2018.
• Medtech set to outperform prescription drug market with CAGR of 4.5% vs. 3.8% between 2012 and 2018 – but pharma forecast to catch up, with both industries estimated to grow by approximately 5% from 2015 to 2018
• Johnson & Johnson to be clear market leader in 2018 with medtech sales of $33.4bn
• In vitro diagnostics expected to be the world’s largest medtech segment in 2018, with sales of $58.8bn
• Global medtech R&D spend set to grow by 3.9% (CAGR) to $26.7bn by 2018

To download you own complimentary copy of the latest edition, complete the form opposite.